Man Group
ZVRA icon

Man Group’s Zevra Therapeutics ZVRA Stock Holding History

Man Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92,347
Closed -$827K – 2619
2025
Q4 		$827K Buy
92,347
+58,695
+174% +$555K ﹤0.01% 1730
2025
Q3 		$320K Buy
+33,652
New +$337K ﹤0.01% 1981
2025
Q2 		– Sell
-22,448
Closed -$168K – 2453
2025
Q1 		$168K Buy
+22,448
New +$178K ﹤0.01% 2058
2023
Q2 		– Hold
0
– -$124K – 2270
2023
Q1 		– Sell
-33,046
Closed -$175K – 1929
2022
Q4 		$152K Buy
33,046
+3,768
+13% +$19.1K ﹤0.01% 1825
2022
Q3 		$183K Buy
+29,278
New +$166K ﹤0.01% 1786
2022
Q2 		– Hold
0
– – – 1725

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return